, Volume 225, Issue 1, pp 31–39 | Cite as

The influence of NMDA and GABAA receptors and glutamic acid decarboxylase (GAD) activity on attention

  • Alan L. Pehrson
  • Corina O. Bondi
  • Nelson K. B. Totah
  • Bita MoghaddamEmail author
Original Investigation



Attention dysfunction is the hallmark of cognitive deficits associated with major psychiatric illnesses including schizophrenia. Cognitive deficits of schizophrenia have been attributed to reduced function of the N-methyl-d-aspartate (NMDA) receptor or reduced expression of the gamma-aminobutyric acid (GABA)-synthesizing enzyme glutamic acid decarboxylase-67, which presumably leads to attenuated neurotransmission at GABAA receptors.


The present study used a rodent model to compare the inhibition of NMDA and GABAA receptors, and GAD activity on attention. We tested the impact of inhibiting these proteins brain wide or in the anterior cingulate cortex (ACC), a prefrontal cortex region critical for attentional processing.


Rats were trained on the three choice serial reaction time task (3-CSRT), an attention test. The impact of systemic or intra-ACC injection of drugs on performance was measured in well-trained rats.


Reducing GABAA receptor function within the ACC with the direct antagonist SR95531 (1 or 3 ng/side) or brain wide using systemic injection of the benzodiazepine inverse agonist FG7142 (5 mg/kg) impaired accuracy and increased omissions. Systemic or intra-ACC inhibition of NMDA receptors using MK-801 (at 3 mg/kg or 3 μg, respectively) also impaired performance. Inhibition of GAD with 3-mercaptopropionic acid, even at high doses, had no effect on 3-CSRT accuracy or omissions when administered systemically or within the ACC.


These data demonstrate that, while tonic stimulation of NMDA and GABAA receptors within the ACC are critical for attentional performance, reduction in GAD activity may have little functional significance and is not indicative of reduced GABA neurotransmission.


Schizophrenia Attention Glutamate GABA Glutamic acid decarboxylase 



This study was supported by National Institute of Mental Health Grant MH84906, Andrew Mellon Foundation Predoctoral Fellowship Grant (to N. K. B. T.), and NRSA Training Grant T32 MH018273 (to C. O. B.)


  1. Adler CM, Malhotra AK, Elman I, Goldberg T, Egan M, Pickar D, Breier A (1999) Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia. American Journal of Psychiatry 156:1646–1649PubMedGoogle Scholar
  2. Ahn K, Gil R, Seibyl J, Sewell RA, D’Souza DC (2011) Probing GABA receptor function in schizophrenia with iomazenil. Neuropsychopharmacology 36:677–683PubMedCrossRefGoogle Scholar
  3. Akbarian Rt (1995) Reduced inhibitory capacity in prefrontal cortex of schizophrenics. Archives of General Psychiatry 52:267–278CrossRefGoogle Scholar
  4. Andreasen NC (1999) A unitary model of schizophrenia—Bleuler’s “fragmented phrene” as schizencephaly. Archives of General Psychiatry 56:781–787PubMedCrossRefGoogle Scholar
  5. Belforte JE, Zsiros V, Sklar ER, Jiang Z, Yu G, Li Y, Quinlan EM, Nakazawa K (2010) Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nature neuroscience 13:76–83PubMedCrossRefGoogle Scholar
  6. Brier A, Davis O, Buchanan R, Listwak SJ, Holmes C, Pickar D, Goldstein DS (1992) Effects of alprazolam on pituitary-adrenal and catecholaminergic response to metabolic stress in humans. Biological Psychiatry 32:880–890CrossRefGoogle Scholar
  7. Bussey T, Muir J, Everitt B, Robbins T (1997) Triple dissociation of anterior cingulate, posterior cingulate, and medial frontal cortices on visual discrimination tasks using a touchscreen testing procedure for the rat. Behavioral Neuroscience 11:920–936CrossRefGoogle Scholar
  8. Carli M, Robbins TW, Evenden JL, Everitt BJ (1983) Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav Brain Res 9:361–380PubMedCrossRefGoogle Scholar
  9. Carli M, Baviera M, Invernizzi RW, Balducci C (2006) Dissociable contribution of 5-HT1A and 5-HT2A receptors in the medial prefrontal cortex to different aspects of executive control such as impulsivity and compulsive perseveration in rats. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology 31:757–767CrossRefGoogle Scholar
  10. Chudasama Y, Passetti F, Rhodes SE, Lopian D, Desai A, Robbins TW (2003) Dissociable aspects of performance on the 5-choice serial reaction time task following lesions of the dorsal anterior cingulate, infralimbic and orbitofrontal cortex in the rat: differential effects on selectivity, impulsivity and compulsivity. Behav Brain Res 146:105–119PubMedCrossRefGoogle Scholar
  11. Corbetta M, Miezin FM, Dobmeyer S, Shulman GL, Petersen SE (1991) Selective and divided attention during visual discriminations of shape, color, and speed: functional anatomy by positron emission tomography. J Neurosci 11:2383–2402PubMedGoogle Scholar
  12. Curley AA, Lewis DA (2012) Cortical basket cell dysfunction in schizophrenia. J Physiol 590:715–724PubMedGoogle Scholar
  13. Francois J, Ferrandon A, Koning E, Angst MJ, Sandner G, Nehlig A (2009) Selective reorganization of GABAergic transmission in neonatal ventral hippocampal-lesioned rats. Int J Neuropsychopharmacol 12:1097–1110PubMedCrossRefGoogle Scholar
  14. Gold JM (2004) Cognitive deficits as treatment targets in schizophrenia. Schizophr Res 72:21–28PubMedCrossRefGoogle Scholar
  15. Gold S, Arndt S, Nopoulos P, O’Leary DS, Andreasen NC (1999) Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia. American Journal of Psychiatry 156:1342–1348PubMedGoogle Scholar
  16. Goldberg TE, Weinberger DR (1987) Methodological issues in the neuropsychological approach to schizophrenia. Elsevier Science, New YorkGoogle Scholar
  17. Gonzalez-Burgos G, Hashimoto T, Lewis DA (2010) Alterations of cortical GABA neurons and network oscillations in schizophrenia. Curr Psychiatry Rep 12:335–344PubMedCrossRefGoogle Scholar
  18. Goto N, Yoshimura R, Moriya J, Kakeda S, Ueda N, Ikenouchi-Sugita A, Umene-Nakano W, Hayashi K, Oonari N, Korogi Y, Nakamura J (2009) Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3 T Proton MRS study. Schizophr Res 112:192–193PubMedCrossRefGoogle Scholar
  19. Green M (1996) What are the functional consequences of neurocognitive deficits in schizophrenia. American Journal of Psychiatry 153:321–330PubMedGoogle Scholar
  20. Green MF, Kern RS, Braff DL, Mintz J (2000) Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophr Bull 26:119–136PubMedCrossRefGoogle Scholar
  21. Grottick AJ, Higgins GA (2000) Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task. Behav Brain Res 117:197–208PubMedCrossRefGoogle Scholar
  22. Herbison AE, Heavens RP, Dyer RG (1990) Endogenous release of gamma-aminobutyric acid from the medial preoptic area measured by microdialysis in the anaesthetised rat. J. Neurochem 55(5):1617–1623Google Scholar
  23. Huang-Pollock CL, Karalunas SL, Tam H, Moore AN (2012) Evaluating vigilance deficits in ADHD: a meta-analysis of CPT performance. J Abnormal Psychol 121:360–371Google Scholar
  24. Kegeles LS, Mao X, Stanford AD, Girgis R, Ojeil N, Xu X, Gil R, Slifstein M, Abi-Dargham A, Lisanby SH, Shungu DC (2012) Elevated prefrontal cortex gamma-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy. Arch Gen Psychiatry 69:449–459Google Scholar
  25. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr, Charney DS (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51:199–214PubMedCrossRefGoogle Scholar
  26. Lamar C Jr (1970) Mercaptopropionic acid: a convulsant that inhibits glutamate decarboxylase. J Neurochem 17:165–170PubMedCrossRefGoogle Scholar
  27. Laurent A, Saoud M, Bougerol T, d’Amato T, Anchisi AM, Biloa-Tang M, Dalery J, Rochet T (1999) Attentional deficits in patients with schizophrenia and in their non-psychotic first-degree relatives. Psychiatry Res 89:147–159PubMedCrossRefGoogle Scholar
  28. Lewis DA, Moghaddam B (2006) Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations. Arch Neurol 63:1372–1376PubMedCrossRefGoogle Scholar
  29. Lewis DA, Hashimoto T, Volk DW (2005) Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 6:312–324PubMedCrossRefGoogle Scholar
  30. Lipska BK, Lerman DN, Khaing ZZ, Weickert CS, Weinberger DR (2003) Gene expression in dopamine and GABA systems in an animal model of schizophrenia: effects of antipsychotic drugs. Eur J Neurosci 18:391–402PubMedCrossRefGoogle Scholar
  31. Luck SJ, Ford JM, Sarter M, Lustig C (2012) CNTRICS final biomarker selection: control of attention. Schizophrenia bulletin 38:53–61PubMedCrossRefGoogle Scholar
  32. Martin DL, Rimvall K (1993) Regulation of gamma-aminobutyric acid synthesis in the brain. Journal of Neurochemistry 60:395–407PubMedCrossRefGoogle Scholar
  33. Marvel CL, Paradiso S (2004) Cognitive and neurological impairment in mood disorders. Psychiatr Clin North Am 27:19–36, vii-viiiPubMedCrossRefGoogle Scholar
  34. Mazurkiewicz M, Sirvio J, Riekkinen P Sr (1992) Effects of single and repeated administration of vigabatrin on the performance of rats in a 5-choice serial reaction time task. Epilepsy Res 13:231–237PubMedCrossRefGoogle Scholar
  35. Miner LA, Sarter M (1999) Intra-accumbens infusions of antisense oligodeoxynucleotides to one isoform of glutamic acid decarboxylase mRNA, GAD65, but not to GAD67 mRNA, impairs sustained attention performance in the rat. Brain Res Cogn Brain Res 7:269–283PubMedCrossRefGoogle Scholar
  36. Muir JL, Everitt BJ, Robbins TW (1996) The cerebral cortex of the rat and visual attentional function: dissociable effects of mediofrontal, cingulate, anterior dorsolateral, and parietal cortex lesions on a five-choice serial reaction time task. Cerebral Cortex 6:470–481PubMedCrossRefGoogle Scholar
  37. Murphy ER, Fernando AB, Urcelay GP, Robinson ES, Mar AC, Theobald DE, Dalley JW, Robbins TW (2012) Impulsive behaviour induced by both NMDA receptor antagonism and GABA(A) receptor activation in rat ventromedial prefrontal cortex. Psychopharmacology 219:401–410PubMedCrossRefGoogle Scholar
  38. Ongur D, Prescot AP, McCarthy J, Cohen BM, Renshaw PF (2010) Elevated gamma-aminobutyric acid levels in chronic schizophrenia. Biological psychiatry 68:667–670PubMedCrossRefGoogle Scholar
  39. Paine TA, Carlezon WA Jr (2009) Effects of antipsychotic drugs on MK-801-induced attentional and motivational deficits in rats. Neuropharmacology 56:788–797PubMedCrossRefGoogle Scholar
  40. Paine TA, Tomasiewicz HC, Zhang K, Carlezon WA Jr (2007) Sensitivity of the five-choice serial reaction time task to the effects of various psychotropic drugs in Sprague–Dawley rats. Biol Psychiatry 62:687–693PubMedCrossRefGoogle Scholar
  41. Paine TA, Slipp LE, Carlezon WA Jr (2011) Schizophrenia-like attentional deficits following blockade of prefrontal cortex GABAA receptors. Neuropsychopharmacology 36:1703–1713PubMedCrossRefGoogle Scholar
  42. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates. Academic, San DiegoGoogle Scholar
  43. Payne R (1961) Cognitive abnormalities. Basic Books, New YorkGoogle Scholar
  44. Porter RJ, Bourke C, Gallagher P (2007) Neuropsychological impairment in major depression: its nature, origin and clinical significance. Aust N Z J Psychiatry 41:115–128PubMedCrossRefGoogle Scholar
  45. Ragozzino ME, Rozman S (2007) The effect of rat anterior cingulate inactivation on cognitive flexibility. Behav Neurosci 121:698–706PubMedCrossRefGoogle Scholar
  46. Ross SM (2003) Peirce’s criterion for the elimination of suspect experimental data. J Eng Technol 20:38–41Google Scholar
  47. Rudolph U, Knoflach F (2011) Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes. Nat Rev Drug Discov 10:685–697PubMedCrossRefGoogle Scholar
  48. Tayoshi S, Nakataki M, Sumitani S, Taniguchi K, Shibuya-Tayoshi S, Numata S, Iga J, Ueno S, Harada M, Ohmori T (2010) GABA concentration in schizophrenia patients and the effects of antipsychotic medication: a proton magnetic resonance spectroscopy study. Schiz research 117:83–91CrossRefGoogle Scholar
  49. Thompson M, Weickert CS, Wyatt E, Webster MJ (2009) Decreased glutamic acid decarboxylase(67) mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders. J Psychiatr Res 43:970–977PubMedCrossRefGoogle Scholar
  50. Totah NK, Kim YB, Homayoun H, Moghaddam B (2009) Anterior cingulate neurons represent errors and preparatory attention within the same behavioral sequence. The Journal of neuroscience: the official journal of the Society for Neuroscience 29:6418–6426CrossRefGoogle Scholar
  51. Totah NK, Jackson ME, Moghaddam B (2012) Preparatory attention relies on dynamic interactions between prelimbic cortex and anterior cingulate cortex. Cerebral Cortex doi: 10.1093/cercor/bhs057
  52. Turner CP, DeBenedetto D, Ware E, Stowe R, Lee A, Swanson J, Walburg C, Lambert A, Lyle M, Desai P, Liu C (2010) Postnatal exposure to MK801 induces selective changes in GAD67 or parvalbumin. Exp Brain Res 201:479–488PubMedCrossRefGoogle Scholar
  53. Uhlhaas PJ, Singer W (2010) Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci 11:100–113PubMedCrossRefGoogle Scholar
  54. Vanini G, Watson CJ, Lydic R, Baghdoyan HA (2008) Gamma-aminobutyric acid-mediated neurotransmission in the pontine reticular formation modulates hypnosis, immobility, and breathing during isoflurane anesthesia. Anesthesiology 109(6):978–988.Google Scholar
  55. Volk DW, Lewis DA (2002) Impaired prefrontal inhibition in schizophrenia: relevance for cognitive dysfunction. Physiol Behav 77:501–505PubMedCrossRefGoogle Scholar
  56. Volk DW, Austin MC, Pierri JN, Sampson AR, Lewis DA (2000) Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry 57:237–245PubMedCrossRefGoogle Scholar
  57. Volk D, Austin M, Pierri J, Sampson A, Lewis D (2001) GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons. Am J Psychiatry 158:256–265PubMedCrossRefGoogle Scholar
  58. Yoon JH, Maddock RJ, Rokem A, Silver MA, Minzenberg MJ, Ragland JD, Carter CS (2010) GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression. J Neurosci 30:3777–3781PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Alan L. Pehrson
    • 1
    • 2
  • Corina O. Bondi
    • 1
  • Nelson K. B. Totah
    • 1
    • 3
  • Bita Moghaddam
    • 1
    Email author
  1. 1.Department of NeuroscienceUniversity of PittsburghPittsburghUSA
  2. 2.Lundbeck Research USA, Inc.ParamusUSA
  3. 3.Max Planck Institute for Biological CyberneticsTübingenGermany

Personalised recommendations